Santa Cruz Biotechnology provides a broad selection of cathepsin 6 monoclonal antibodies for research focused on understanding this important protease. Cathepsin 6 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cathepsin 6 is a cysteine protease that plays a crucial role in protein degradation and processing within lysosomes. The protein is involved in various physiological processes, including antigen presentation and apoptosis, making it significant in both normal cellular function and disease states. Dysregulation of cathepsin 6 has been implicated in several pathological conditions, including cancer and neurodegenerative diseases, highlighting its importance as a target for therapeutic intervention. Research has shown that cathepsin 6 activity is essential for maintaining cellular homeostasis and proper protein turnover. Understanding cathepsin 6 function can provide valuable insights into disease mechanisms and potential treatment strategies. Recent studies have demonstrated the significance of cathepsin 6 in immune system regulation and tissue remodeling. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cathepsin 6 and its impact on human health.